Home Weekly Options 3-4-19 ASND biotech stock 53 dollar upside big trade there will be a sell down take put options
  Previous Video 2-26-19 PANW 125 call options Palo Alto Networks beats by $0.29, beats on revs
  Next Video 3-7-19 ALGN Power Play March 19 , 270 put options stock price 266 to 227 big reversal

3-4-19 ASND biotech stock 53 dollar upside big trade there will be a sell down take put options

0
0
0

3-4-19 ASND biotech stock 53 dollar upside big trade there will be a sell down take put options

Call us 702-685-0772 join our trading community online
• 3-4-19 ASND (117.9 +70.11%): Flew to all-time highs at the open after announcing positive top-line results from its Phase 3 heiGHt trial comparing once-weekly TransCon Growth Hormone (hGH) to a daily growth hormone (Genotropin) in children with pediatric growth hormone deficiency; the trial’s primary endpoint was met as TransCon hGH was observed to be non-inferior and, additionally, superior to the daily hGH on the primary endpoint of annualized height velocity at 52 weeks. Co expects top-line data from another TransCon hGH Phase 3 Program, the fliGHt trial, in Q2 of 2019. Co plans a clinical database lock for the TransCon hGH Phase 3 program in the third quarter of 2019 and intends to submit a BLA for TransCon hGH to treat pediatric GHD in the first half of 2020.

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *

Translate »
cycloneslider-slide